5-HT 5A receptor antagonists (Abbott)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Name5-HT 5A receptor antagonists (Abbott)
Drug Alias NameA-763079A-843277A-833551
ClassificationSmall molecules
Mechanisms of Action5-hydroxytryptamine receptor 5A antagonists
Targets5-hydroxytryptamine receptor 5A
Therapy Area/IndicationsSchizophreniaDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Deutschland Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie Deutschland Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepression

Other Information

ATC CodeN/A
Related LinksN/A